← All trials
NCT07208773
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 29, 2025
- Primary completion
- Jan 31, 2027
- Completion date
- Dec 31, 2027
- First posted
- Oct 6, 2025
- Last posted
- Nov 17, 2025
- Enrollment
- 260
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Suzhou Medilink Therapeutics Ltd.Lead sponsor
- Akeso Pharmaceuticals, Inc.Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.